Rare leukemia targeted by modifying patients’ immune cells – West Hartford News
West Hartford News |
Rare leukemia targeted by modifying patients' immune cells
West Hartford News Turning the T cells into CAR–T cells helps by targeting the CD19 marker on the B cells. “CD19 happens to be a pretty good target for cancer technology because it's only on B cells,” Gore said. “These new CAR–T cells latch onto the leukemia cells.”. |
